O'Mahony JF, Risk Stratification in Cost-Effectiveness Analyses of Cancer Screening; Intervention Eligibility, Strategy Choice, and Optimality, Journal of Medical Decision Making, 2021,
Journal Article,
PUBLISHED
DOI
URL
|
O'Mahony, JF, van Rosmalen, J, Mushkudiani, NA, Goudsmit, F-W, Eijkemans, MJ, Heijnsdijk, EA, Steyerberg E & Habbema, JDF, The Influence of Disease Risk on the Optimal Time Interval between Screens for the Early Detection of Cancer A Mathematical Approach, Medical Decision Making, 2014,
Journal Article,
PUBLISHED
DOI
URL
Other
|
van Rosmalen, J, Toy, M, & O'Mahony, JF, A Mathematical Approach for Evaluating Markov Models in Continuous Time without Discrete-Event Simulation, Medical Decision Making, 33, (6), 2013, p767 - 779,
Journal Article,
PUBLISHED
DOI
URL
URL
|
Almajed S, Alotaibi N, Zulfqar S, Dhuhaibawi Z, O'Rourke N, Gaule R, Byrne C, Barry AM, Keeley D, and O'Mahony JF, Cost-efectiveness evidence on approved cancer drugs in Ireland: the limits of data availability and implications for public accountability, The European Journal of Health, 2021,
Journal Article,
PUBLISHED
DOI
URL
|
O'Mahony JF, Revision of Ireland's Cost-Effectiveness Threshold: New State-Industry Drug Pricing Deal Should Adequately Reflect Opportunity Costs, PharmacoEconomics, 2021,
Journal Article,
PUBLISHED
DOI
URL
|
O'Mahony, JF, & Paulden, M, NICE's Selective Application of Differential Discounting: Ambiguous, Inconsistent, and Unjustified, Value in Health: The Journal of The International Society for Pharmacoeconomics and Outcomes Research, 17, (5), 2013, p493 - 496,
Journal Article,
IN_PRESS
DOI
URL
Other
|
O'Mahony, JF, Cost-effectiveness of population-based screening for colorectal cancer, British Journal of Cancer, 108, (5), 2013, p1209 - 1210,
Journal Article,
PUBLISHED
DOI
URL
Other
|
O'Mahony JF, Newall AT, and van Rosmalen J, Dealing with Time in Health Economic Evaluation: Methodological Issues and Recommendations for Practice, PharmacoEconomics, 2015, pDOI 10.1007/s40273-015-0309-4 ,
Journal Article,
PUBLISHED
DOI
URL
Other
|
O'Mahony, JF., van Rosmalen, J, Zauber, AG and van Ballegooijen M, Multicohort Models in Cost-Effectiveness Analysis Why Aggregating Estimates over Multiple Cohorts Can Hide Useful Information, Medical Decision Making, 33, (3), 2013, p407 - 414,
Journal Article,
PUBLISHED
DOI
URL
Other
|
O'Mahony, JF, de Kok, IMCM, van Rosmalen, J, Habbema, JDF, Brouwer, WBF and van Ballegooijen, M, Practical implications of differential discounting in cost-effectiveness analyses with varying numbers of cohorts, Value in Health: The Journal of The International Society for Pharmacoeconomics and Outcomes Research, 14, (4), 2011, p438 - 442,
Journal Article,
PUBLISHED
DOI
URL
Other
|
|